Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 186

  • Filters activated: Cancer. Clear all to show 204 items.
1.

Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.

Liu BY, He XY, Zhuo RX, Cheng SX.

Nanoscale. 2018 Nov 12. doi: 10.1039/c8nr07321j. [Epub ahead of print]

PMID:
30417194
2.

Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.

Sharma VR, Thomas SD, Miller DM, Rezzoug F.

Cancer Invest. 2018 Nov 5:1-17. doi: 10.1080/07357907.2018.1527930. [Epub ahead of print]

PMID:
30396283
3.

AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

Vandghanooni S, Eskandani M, Barar J, Omidi Y.

Nanomedicine (Lond). 2018 Nov;13(21):2729-2758. doi: 10.2217/nnm-2018-0205. Epub 2018 Nov 5.

PMID:
30394201
4.

A dual-signal amplification platform for sensitive fluorescence biosensing of leukemia-derived exosomes.

Huang L, Wang DB, Singh N, Yang F, Gu N, Zhang XE.

Nanoscale. 2018 Nov 8;10(43):20289-20295. doi: 10.1039/c8nr07720g.

PMID:
30371719
5.

Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.

Liu BY, He XY, Zhuo RX, Cheng SX.

J Control Release. 2018 Dec 10;291:90-98. doi: 10.1016/j.jconrel.2018.10.018. Epub 2018 Oct 16.

PMID:
30339905
6.

AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice.

Ghahremani F, Kefayat A, Shahbazi-Gahrouei D, Motaghi H, Mehrgardi MA, Haghjooy-Javanmard S.

Nanomedicine (Lond). 2018 Oct;13(20):2563-2578. doi: 10.2217/nnm-2018-0180. Epub 2018 Oct 18.

PMID:
30334677
7.

MnO2-gated Nanoplatforms with Targeted Controlled Drug Release and Contrast-Enhanced MRI Properties: from 2D Cell Culture to 3D Biomimetic Hydrogels.

Shi Y, Guenneau F, Wang X, Hélary C, Coradin T.

Nanotheranostics. 2018 Sep 21;2(4):403-416. doi: 10.7150/ntno.28046. eCollection 2018.

8.

Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma.

Zhu X, Zhou H, Liu Y, Wen Y, Wei C, Yu Q, Liu J.

Acta Biomater. 2018 Oct 11. pii: S1742-7061(18)30602-0. doi: 10.1016/j.actbio.2018.10.012. [Epub ahead of print]

PMID:
30316026
9.

A Core-Shell Nanoplatform for Synergistic Enhanced Sonodynamic Therapy of Hypoxic Tumor via Cascaded Strategy.

Wang L, Niu M, Zheng C, Zhao H, Niu X, Li L, Hu Y, Zhang Y, Shi J, Zhang Z.

Adv Healthc Mater. 2018 Oct 10:e1800819. doi: 10.1002/adhm.201800819. [Epub ahead of print]

PMID:
30303621
10.

G-Quadruplex-Based Nanoscale Coordination Polymers to Modulate Tumor Hypoxia and Achieve Nuclear-Targeted Drug Delivery for Enhanced Photodynamic Therapy.

Yang Y, Zhu W, Feng L, Chao Y, Yi X, Dong Z, Yang K, Tan W, Liu Z, Chen M.

Nano Lett. 2018 Nov 14;18(11):6867-6875. doi: 10.1021/acs.nanolett.8b02732. Epub 2018 Oct 10.

PMID:
30303384
11.

DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.

Li N, Xiang MH, Liu JW, Tang H, Jiang JH.

Anal Chem. 2018 Nov 6;90(21):12951-12958. doi: 10.1021/acs.analchem.8b03253. Epub 2018 Oct 19.

PMID:
30303006
12.

Engineering a customized nanodrug delivery system at the cellular level for targeted cancer therapy.

Li J, Qiu L, Xie S, Zhang J, Zhang L, Liu H, Li J, Zhang X, Tan W.

Sci China Chem. 2018 Apr;61(4):497-504. doi: 10.1007/s11426-017-9176-3. Epub 2018 Jan 11.

PMID:
30271427
13.

Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.

Abnous K, Danesh NM, Ramezani M, Charbgoo F, Bahreyni A, Taghdisi SM.

Expert Opin Drug Deliv. 2018 Nov;15(11):1045-1052. doi: 10.1080/17425247.2018.1530656. Epub 2018 Oct 5.

PMID:
30269603
14.

Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency.

Han Y, Ding B, Zhao Z, Zhang H, Sun B, Zhao Y, Jiang L, Zhou J, Ding Y.

Biomaterials. 2018 Dec;185:205-218. doi: 10.1016/j.biomaterials.2018.09.016. Epub 2018 Sep 13.

PMID:
30245388
15.

Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment.

Tekie FSM, Soleimani M, Zakerian A, Dinarvand M, Amini M, Dinarvand R, Arefian E, Atyabi F.

Carbohydr Polym. 2018 Dec 1;201:131-140. doi: 10.1016/j.carbpol.2018.08.060. Epub 2018 Aug 17.

PMID:
30241804
16.

DNA Octahedron-Based Fluorescence Nanoprobe for Dual Tumor-Related mRNAs Detection and Imaging.

Zhong L, Cai S, Huang Y, Yin L, Yang Y, Lu C, Yang H.

Anal Chem. 2018 Oct 16;90(20):12059-12066. doi: 10.1021/acs.analchem.8b02847. Epub 2018 Oct 2.

PMID:
30223642
17.

Metal-Organic Framework-Based Nanoplatform for Intracellular Environment-Responsive Endo/Lysosomal Escape and Enhanced Cancer Therapy.

Dong K, Wang Z, Zhang Y, Ren J, Qu X.

ACS Appl Mater Interfaces. 2018 Sep 26;10(38):31998-32005. doi: 10.1021/acsami.8b11972. Epub 2018 Sep 13.

PMID:
30178654
18.

Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.

Riccardi C, Musumeci D, Russo Krauss I, Piccolo M, Irace C, Paduano L, Montesarchio D.

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1384-1399. doi: 10.1016/j.ijbiomac.2018.06.137. Epub 2018 Jul 4.

PMID:
30170359
19.

T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents.

Li J, You J, Wu C, Dai Y, Shi M, Dong L, Xu K.

Int J Nanomedicine. 2018 Aug 10;13:4607-4625. doi: 10.2147/IJN.S168660. eCollection 2018.

20.

[Development and evaluation of ultrasound contrast agents with AS1411-conjugated nanoparticles with liquid core].

Wang Z, Ding J, Luo S, Wang P, Liang Q.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jun 28;43(6):610-618. doi: 10.11817/j.issn.1672-7347.2018.06.006. Chinese.

Supplemental Content

Loading ...
Support Center